FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34743111000001109: Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105004901000001116 Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105005001000001116 Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Soluble tablet true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Dexamethasone 2mg soluble tablets sugar free true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has active ingredient Dexamethasone true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form Soluble tablet false Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Dexamethasone sodium phosphate true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dexamethasone true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Glensoludex true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has basis of strength substance Dexamethasone true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form Soluble tablet true Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 50 tablet Has AMP True Glensoludex 2mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start